Vasopressor therapy for advanced cardiac life support

Research output: Contribution to journalArticle

Abstract

Epinephrine has been the standard vasopressor for use during cardiac arrest since the inception of modern CPR. The effectiveness of epinephrine is due to its ability to increase myocardial oxygen supply by improving coronary blood flow and pressure through peripheral vasoconstriction. Myocardial stimulation through beta-adrenergic receptors is unimportant for resuscitation. Pure alpha-adrenergic agents have been found to have similar success to epinephrine but no better. When used for initial therapy for cardiac arrest, higher doses of epinephrine have not been found to promote better survival than the standard 0.015 mg/kg dose.

Original languageEnglish (US)
Pages (from-to)835-847
Number of pages13
JournalAnesthesiology Clinics of North America
Volume13
Issue number4
StatePublished - 1995

Fingerprint

Advanced Cardiac Life Support
Epinephrine
Heart Arrest
Receptors, Adrenergic, beta
Cardiopulmonary Resuscitation
Therapeutics
Vasoconstriction
Resuscitation
Adrenergic Agents
Oxygen
Blood Pressure

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Vasopressor therapy for advanced cardiac life support. / Otto, Charles W.

In: Anesthesiology Clinics of North America, Vol. 13, No. 4, 1995, p. 835-847.

Research output: Contribution to journalArticle

@article{531299384cfb48f2a23d2c872aff7d83,
title = "Vasopressor therapy for advanced cardiac life support",
abstract = "Epinephrine has been the standard vasopressor for use during cardiac arrest since the inception of modern CPR. The effectiveness of epinephrine is due to its ability to increase myocardial oxygen supply by improving coronary blood flow and pressure through peripheral vasoconstriction. Myocardial stimulation through beta-adrenergic receptors is unimportant for resuscitation. Pure alpha-adrenergic agents have been found to have similar success to epinephrine but no better. When used for initial therapy for cardiac arrest, higher doses of epinephrine have not been found to promote better survival than the standard 0.015 mg/kg dose.",
author = "Otto, {Charles W}",
year = "1995",
language = "English (US)",
volume = "13",
pages = "835--847",
journal = "Anesthesiology Clinics of North America",
issn = "0889-8537",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Vasopressor therapy for advanced cardiac life support

AU - Otto, Charles W

PY - 1995

Y1 - 1995

N2 - Epinephrine has been the standard vasopressor for use during cardiac arrest since the inception of modern CPR. The effectiveness of epinephrine is due to its ability to increase myocardial oxygen supply by improving coronary blood flow and pressure through peripheral vasoconstriction. Myocardial stimulation through beta-adrenergic receptors is unimportant for resuscitation. Pure alpha-adrenergic agents have been found to have similar success to epinephrine but no better. When used for initial therapy for cardiac arrest, higher doses of epinephrine have not been found to promote better survival than the standard 0.015 mg/kg dose.

AB - Epinephrine has been the standard vasopressor for use during cardiac arrest since the inception of modern CPR. The effectiveness of epinephrine is due to its ability to increase myocardial oxygen supply by improving coronary blood flow and pressure through peripheral vasoconstriction. Myocardial stimulation through beta-adrenergic receptors is unimportant for resuscitation. Pure alpha-adrenergic agents have been found to have similar success to epinephrine but no better. When used for initial therapy for cardiac arrest, higher doses of epinephrine have not been found to promote better survival than the standard 0.015 mg/kg dose.

UR - http://www.scopus.com/inward/record.url?scp=0029560937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029560937&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029560937

VL - 13

SP - 835

EP - 847

JO - Anesthesiology Clinics of North America

JF - Anesthesiology Clinics of North America

SN - 0889-8537

IS - 4

ER -